Engineered Cell Platforms For Profiling Off-Target TCR Allo- Reactivity And Cross-Reactivity

Time: 5:00 pm
day: Day One

Details:

  • Precise characterization of TCR off-target activity is critical to success of TCR-based cellular therapies
  • Utilization of engineered cell platforms as analytical tools enables high-precision characterization of allo-reactivity and cross-reactivity phenomena
  • Anocca’s assay technologies reveal fundamental insights into molecular basis of allo- and cross- reactivity

Speakers: